 SALT LAKE CITY, Feb. 16, 2022 GLOBE NEWSWIRE -- Myriad Genetics, Inc., NASDAQ: MYGN, a leader in genetic testing and precision medicine, will hold its 2021 fourth-quarter earnings conference call on Thursday, February 24, 2022 at 4:30 p.m. ET. The companys quarterly earnings will be released the same day prior to the market opening. 